Ivan Holman

Morgan Stanley recently issued a report on CDK Global Inc (NASDAQ: CDK) after expectations of end market consolidation and limited international reach. Morgan Stanley downgraded CDK Global from Equal-weight to Underweight, while raising the price target from $45 to $46. Analysts Brian Essex,...